/Companies

BreezeBio Venture Capital

64 employees on LinkedIn · 4 known investors

Find your way into BreezeBio Venture Capital

Sign up to see every warm intro you have to BreezeBio Venture Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BreezeBio Venture Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues. The platform addresses the challenge of enabling genetic payloads to reach their target sites in the body to control biological processes.

Founders & leadership

KL
Kunwoo LeeChief Executive Officer & Co-founder30 Under 30 2018
BS
BreezeBio since heFounder
HM
Hyo Min ParkFounder

Investors · 4

Frequently asked questions

What does BreezeBio Venture Capital do?
BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues. The platform addresses the challenge of enabling genetic payloads to reach their target sites in the body to control biological processes.
Who founded BreezeBio Venture Capital?
BreezeBio Venture Capital was founded by Kunwoo Lee.
Who are BreezeBio Venture Capital's investors?
BreezeBio Venture Capital's investors include Blue Bear Ventures, Bow Capital, IMM Investment Japan, DCVC (Data Collective).